Cefixoral

Quick links to important sections

Cefixoral

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefixoral

What is Cefixoral? (Overview)

Cefixoral is a brand-name prescription drug containing the active ingredient cefixime. It is an oral broad-spectrum antibiotic used to treat a variety of bacterial infections. As a prescription-only (Rx) medication, Cefixoral must be prescribed by a healthcare provider.

Property Description
Active Ingredient Cefixime
Pharmacological Class Third-Generation Cephalosporin Antibiotic
Common Form Oral Capsule, Tablet, or Suspension (liquid)
Primary Use Treatment of bacterial infections (e.g., ear, throat, urinary tract)

Cefixoral belongs to the third-generation cephalosporin class, which is recognized for its effectiveness against a wide range of common bacterial pathogens. It is designed to be absorbed by the body, offering an oral alternative to injectable antibiotics for many types of community-acquired bacterial infections.

Its primary function is to actively kill susceptible bacteria or prevent their growth. This action makes it a treatment for conditions such as infections of the middle ear (otitis media), tonsils, throat (pharyngitis), and urinary tract infections (UTIs).

It is important for patients to understand that Cefixoral, like all antibiotics, is ineffective against viral illnesses, such as the common cold or flu. Its use, guided by a doctor's diagnosis, is essential to ensure the infection is treated and to help address the public health concern of antibiotic resistance.

Regulatory References

  1. Cefixime: MedlinePlus Drug Information

What side effects are possible with Cefixoral?

Possible side effects and safety information

The safety profile of Cefixoral (cefixime) is structured by regulatory bodies to distinguish between common, expected reactions and rare, serious systemic events. Adverse reactions are classified according to incidence rates observed in clinical experience.

The most frequently documented side effects are categorized as Common and involve the Gastrointestinal Disorders system-organ class. These may include diarrhea, loose stools, nausea, and abdominal pain.


Serious Adverse Reactions and Safety Constraints

The regulatory labeling highlights rare but serious risks, which involve multiple organ systems. These are critical safety considerations documented by health authorities:

  • Severe Systemic Risks: These include life-threatening anaphylactic/anaphylactoid reactions and severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS.
  • Gastrointestinal Risk: The potential for severe bowel inflammation, specifically Clostridium difficile-Associated Diarrhea (CDAD) and Pseudomembranous Colitis, is documented. The onset of these symptoms may occur during or after the completion of treatment.
  • Neurological and Renal Risks: The drug carries the beta-lactam class risk of encephalopathy (which may include confusion and convulsions) and Acute Renal Failure. This risk is particularly noted in patients with renal impairment, requiring caution.

Population and Test-Related Safety Notes

The official profile specifies constraints for certain patient groups. Patients with renal impairment are at increased risk of neurological effects if appropriate adjustments are not considered. When Cefixoral is administered to patients receiving anticoagulants, there is a documented potential for prolonged prothrombin time with or without clinical bleeding. Furthermore, the use of cefixime may cause a false-positive direct Coombs' test and interfere with certain urine glucose tests.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of the active ingredient in Cefixoral (cefixime) primarily presents with the risk of serious Central Nervous System (CNS) effects. Documented manifestations in regulatory labeling may include encephalopathy, confusion, movement disorders, and convulsions (seizures). Although gastrointestinal disturbances can occur, in studies involving high single doses, these effects did not significantly differ from those experienced at recommended therapeutic doses.

Required Emergency Action

Due to the potential for severe neurological manifestations, regulatory documentation mandates that individuals must seek emergency medical attention right away and call the Poison Control Center immediately if an overdose is suspected.

Population-Specific Risk: A heightened risk for these severe CNS events, including seizures, is specifically noted in patients with impaired renal function due to the potential for drug accumulation.

Supportive Management Constraints

Official prescribing information states that no specific antidote exists for cefixime overdose. The resulting clinical management is symptomatic and supportive. Furthermore, the drug is not removed in significant quantities by hemodialysis or peritoneal dialysis, which places constraints on procedural interventions. Gastric lavage may be indicated following an acute overdose.

Therapeutic Uses of Cefixoral

Quick Facts: Primary Uses

  • Respiratory Support: May be used to manage acute exacerbations of chronic bronchitis.
  • Ear, Nose, and Throat: Helps address infections of the middle ear (otitis media), tonsillitis, and pharyngitis.
  • Urinary Tract: Indicated for the treatment of uncomplicated urinary tract infections (UTIs).
  • Other Infections: May be prescribed for uncomplicated gonorrhea (cervical/urethral).

Cefixoral is a prescription antibacterial agent used for the management of various infections caused by susceptible bacteria. It works by interfering with the development of the bacteria’s cell wall, which may help resolve the infection.

The medication is indicated for use in adults and pediatric patients six months of age and older. Its primary therapeutic domains include addressing infections affecting the respiratory system, such as acute exacerbations of chronic bronchitis, and common infections of the ear, such as otitis media. It can also be used for infections of the throat, including pharyngitis and tonsillitis.

Furthermore, Cefixoral is an option for the treatment of uncomplicated urinary tract infections and uncomplicated gonorrhea. Using this or any antibiotic only to treat infections proven or strongly suspected to be caused by bacteria is recommended to maintain effectiveness and reduce the development of drug-resistant organisms.

Eligibility and Restrictions for Use

Eligibility Scope

Populations for whom use is contraindicated: Cefixoral is formally contraindicated in individuals with a known hypersensitivity to the active ingredient, cefixime, or to any other antibiotic in the cephalosporin class. Due to the documented risk of cross-allergenicity, patients with a history of severe immediate hypersensitivity to penicillin are also prohibited from use.

Age-related eligibility rules: Treatment is officially established for adults and pediatric patients six months of age or older. The safety and efficacy in infants less than six months of age have not been established by regulators, making them ineligible under standard conditions.

Condition-specific eligibility rules: Patients with impaired renal function require restricted use; those with creatinine clearance less than 60 mL/min must have their dose adjusted. Use requires caution in patients with a history of bleeding problems or severe gastrointestinal disease. The chewable formulation is restricted for patients with Phenylketonuria (PKU) due to the presence of phenylalanine.

Pregnancy and lactation eligibility status: During pregnancy, Cefixoral should be used only if clearly needed. For nursing mothers, regulatory documents state that consideration should be given to discontinuing nursing temporarily during the course of treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cefixoral (cefixime) has officially documented interaction patterns that primarily involve altered systemic drug exposure and effects on blood coagulation, as detailed in regulatory sources.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class Official Interaction Outcome (As Labeled)
Coumarin-type Anticoagulants (e.g., Warfarin) Increased Prothrombin Time (PT), reflecting an enhanced effect on coagulation parameters.
Probenecid Increases Cefixoral's systemic exposure (AUC and Cmax) by inhibiting its renal clearance.
Salicylates (specific doses) Results in a 20-25% decrease in Cefixoral's systemic exposure (Cmax and AUC).
Carbamazepine Elevated plasma levels of carbamazepine have been officially reported upon co-administration.

Interaction-Related Restrictions

Co-administration with live bacterial vaccines, such as the oral Typhoid vaccine or BCG vaccine live, may result in a formal reduction of the vaccine's intended efficacy. Furthermore, food does not alter the overall amount of Cefixoral absorbed, but it does decrease the rate of absorption.

Mechanism of Action

How Cefixoral Works

The mechanism of cefixime, the active ingredient in Cefixoral, involves the disruption of bacterial structure and integrity at a molecular level.


Irreversible Inhibition of Cell Wall Synthesis

Cefixime functions by targeting and irreversibly inhibiting Penicillin-Binding Proteins (PBPs), a class of essential bacterial enzymes. Specifically, the drug blocks the final step of peptidoglycan cross-linking, which is necessary to build the rigid cell wall. This action is bactericidal, initiating a cascade that leads directly to the physiological consequence of cell destruction.


Lysis and Death of the Pathogen

The molecular blockade of the PBPs results in a structurally unstable and defective cell wall. Unable to withstand its own internal osmotic pressure, the bacterial cell wall ruptures, leading to cell lysis (death). This process leads to the lysis and death of the actively growing and dividing bacterial organisms, which constitutes the drug's core physiological consequence.


Mechanistic Limitations via Resistance

The inhibitory function of this mechanism is constrained by bacterial counter-measures. Resistance can arise from the enzymatic inactivation of cefixime by bacterial β-lactamases, or by the bacteria genetically altering the structure of their PBP targets, thereby decreasing the drug's binding affinity and subsequent inhibitory function against the PBP targets.

Dosage and Administration Information

How to Use Cefixoral

Cefixoral (cefixime) is administered via the oral route in the form of tablets, capsules, or an oral suspension.

Administration Principle Description
Standard Dosing The typical adult regimen is 400 mg per day, administered either as a single dose or divided into 200 mg doses taken every 12 hours.
Food Intake The medicine may be taken without regard to food (with or without meals).
Duration of Course Treatment duration generally runs from 7 to 14 days, with specific minimum requirements, such as 10 days for infections caused by Streptococcus pyogenes.
Dose for Gonorrhea The dose for uncomplicated N. gonorrhoeae infection is a single oral dose of 400 mg.

Population-Specific Use and Preparation

Specific dose reductions are utilized for certain patient populations. For adults with severely impaired renal function (creatinine clearance below 20 mL/min), the total daily dose is reduced and should not exceed 200 mg once daily. Pediatric patients (aged 6 months and older) receive a weight-based dose of 8 mg/kg/day.

The oral suspension requires reconstitution with a measured volume of water before the initial use, while chewable tablets must be chewed or crushed prior to swallowing. If a dose is missed, it is generally skipped if it is close to the time for the next scheduled dose, and the regular schedule is resumed. This establishes the standardized procedural structure for the use of Cefixoral.

Recent Clinical Evidence

Cefixoral: Recent Clinical Evidence


Research on Outcomes and Functional Status

Studies have examined pain scores as a primary measure and research has also investigated changes in markers associated with inflammation. These studies focus on the scope of the drug’s potential effect on various symptoms.

Key research has investigated mobility across various functional assessments in study participants, and also examined outcomes reported in quality of life scales used by investigators to gauge the drug's role in daily function.

Pharmacological Properties and Comparative Studies

Research has detailed the drug’s pharmacological properties as reported by the investigators. Cefixoral belongs to the class of third-generation cephalosporin antibiotics.

The use of Cefixoral has been studied in research, with investigators investigating study findings in relation to other available therapeutic approaches that are used for similar conditions.

Adverse Event Data and Participant Use

Adverse event data collected across different adult study populations has been reported by the investigators. Additionally, research examined the reported adverse events for participants with pre-existing cardiovascular conditions to understand the drug's profile in diverse populations.

Information regarding how participants took the drug in the research studies was reported by the investigators. Research has examined the potential role of combining the study drug with physical therapy to see if this combination might be associated with different outcomes compared to the drug alone.

Key Studies & References

  1. Cephalosporins: Indications and Appropriate Use in Clinical Practice (Authoritative Guideline/Review)

Frequently Asked Questions (FAQ)

Common questions about Cefixoral (FAQ)


Q: How quickly should I expect Cefixoral to start working?

A: Cefixoral works by actively killing susceptible bacteria that are causing the infection. While the drug starts working immediately, official information indicates that patients commonly begin to see improvement in their symptoms within the first few days of starting treatment. Regulatory guidance emphasizes the importance of completing the full prescribed treatment course.


Q: Is it normal to feel a bit nauseous after taking Cefixoral?

A: Yes, regulatory documents list nausea as a frequently documented side effect of Cefixoral. It is categorized among the most common adverse reactions, which often involve the gastrointestinal system, along with loose stools or diarrhea.


Q: How long does Cefixoral typically stay in your system after the last dose?

A: The elimination of Cefixoral occurs primarily through the kidneys. Official pharmacological data indicates the drug has an elimination half-life of approximately 3 to 4 hours. This means it takes several hours after the final dose for the body to clear the medication.


Q: Are there any major interactions between Cefixoral and common pain relievers like ibuprofen?

A: Official drug labeling documents specific interactions between Cefixoral and salicylates, which are a class of pain relievers. While ibuprofen (an NSAID) is not always listed specifically, patients should discuss any potential interactions with a healthcare provider.


Q: What should I do if I forget to take a Cefixoral dose?

A: Official guidance from health authorities advises that if a dose is missed, it should generally be skipped if it is close to the time for your next scheduled dose. The patient should resume the regular dosing schedule and should not take a double dose to compensate for the missed one.


Q: What's the difference between Cefixoral tablets and suspension?

A: Cefixoral is available in different oral forms, including tablets, capsules, and a liquid suspension. The suspension is typically used for children or those who cannot swallow pills and requires mixing with a measured volume of water before use. Tablets and capsules are swallowed, while chewable tablets must be crushed or chewed.


Q: Is Cefixoral generally considered safe for older adults?

A: Adults with severely impaired renal function (kidney problems) are specifically addressed in regulatory information, as dose restrictions are mandated for this group. Caution is advised for older adults, and official information notes that a dose adjustment may be necessary in the setting of reduced kidney function.


Q: Are there any long-term side effects associated with Cefixoral use?

A: Regulatory warnings indicate that prolonged or repeated use of antibiotics, including Cefixoral, can increase the risk of certain adverse events like Clostridium difficile-associated diarrhea (CDAD). This is caused by an overgrowth of bacteria in the colon, and symptoms can occur even after treatment completion.


Q: Why is Cefixoral sometimes prescribed for urinary tract infections (UTIs)?

A: Cefixoral is officially indicated for the treatment of uncomplicated urinary tract infections (UTIs). It is a third-generation cephalosporin antibiotic effective against the susceptible bacterial strains that commonly cause these types of infections.


Q: Can Cefixoral affect the effectiveness of birth control pills?

A: Official drug guidance indicates that Cefixoral may decrease the effectiveness of hormonal contraceptives, such as birth control pills, patches, rings, or injections. If hormonal birth control is being used, patients are encouraged to review this with a healthcare professional.


Q: Is it possible for Cefixoral to cause a yeast infection?

A: Yes, official adverse event reporting indicates that using this medication can result in an oral thrush or a new vaginal yeast infection. This is due to the overgrowth of non-susceptible organisms, which is a recognized side effect of broad-spectrum antibiotic use.


Q: What are the signs of a non-allergic reaction to Cefixoral?

A: The most common non-allergic reactions often involve the gastrointestinal system and are listed as adverse events like abdominal pain, nausea, loose stools, or mild diarrhea. These reactions are typically expected and documented in the drug's official profile.


Q: Why do some people experience headaches when taking Cefixoral?

A: Headache is officially listed as a potential side effect in the adverse reaction profile of Cefixoral. While it is generally a mild side effect, it is a recognized event that may occur during treatment.


Q: Is Cefixoral effective against Strep throat?

A: Cefixoral is officially indicated for treating infections of the throat and tonsils (pharyngitis and tonsillitis) caused by the bacterium Streptococcus pyogenes, which is the cause of Strep throat. The required treatment course for this specific infection is a minimum of 10 days.


Q: Can Cefixoral cause sun sensitivity or skin rash?

A: Skin rash is a documented side effect of Cefixoral, and it carries warnings regarding severe cutaneous adverse reactions. Additionally, photosensitivity (increased sensitivity to the sun) may be a potential risk noted for this antibiotic class.


Q: How is Cefixoral stored—does it need refrigeration?

A: Official storage instructions state that tablets and capsules must be stored at controlled room temperature. The liquid suspension, once mixed, can be stored either at room temperature or refrigerated, but it must be discarded after 14 days and should never be frozen.


Q: Is Cefixoral a broad-spectrum or narrow-spectrum antibiotic?

A: Cefixoral is classified by health authorities as a broad-spectrum, third-generation cephalosporin antibiotic. This means it is effective against a wide range of common bacterial pathogens.


Q: Does Cefixoral interact with alcohol, and what are the risks?

A: Official documentation does not typically report a major direct drug-alcohol interaction for Cefixoral. However, consuming alcohol may worsen common side effects like nausea or dizziness, and some official guidance suggests patients discuss alcohol consumption with their doctor.


Q: Why might a doctor choose Cefixoral over penicillin for a patient?

A: A healthcare provider might choose Cefixoral for a patient who has a known allergy or severe immediate hypersensitivity to penicillin. This is because cephalosporins belong to a different drug class and may be considered as an alternative option, though caution regarding cross-allergenicity is still necessary.


Q: Does Cefixoral affect blood sugar levels?

A: Cefixoral is known to interfere with certain common laboratory tests for detecting glucose (sugar) in the urine, potentially causing a false-positive reading. Patients who monitor their blood sugar levels are advised to review this potential laboratory test interference with their healthcare provider.


Q: Are there any vitamins or supplements that Cefixoral interacts with?

A: While the drug's official labeling details interactions with other medicines like anticoagulants and probenecid, it does not typically provide a comprehensive list of specific interactions with common over-the-counter vitamins or mineral supplements. All co-administered products should be reviewed by a professional.


Q: How does Cefixoral's mechanism of action differ from macrolide antibiotics?

A: Cefixoral (a cephalosporin) is bactericidal, meaning it kills bacteria by blocking the formation of the bacterial cell wall. This mechanism differs from macrolide antibiotics, which primarily work by inhibiting the bacteria's ability to create necessary proteins.


Q: What are people usually referring to when they mention Cefixoral's benefits?

A: The benefits of Cefixoral, as detailed in regulatory documents, relate to its ability to effectively treat a range of community-acquired bacterial infections, such as those in the middle ear, throat, and urinary tract. It is valued as an oral, broad-spectrum antibiotic option.


Q: Can taking Cefixoral cause dizziness or drowsiness?

A: Dizziness is a documented potential side effect of Cefixoral. While drowsiness is not typically listed as a primary side effect, rare but severe neurological effects (such as confusion or convulsions) are possible, particularly in patients with kidney impairment.

How should Cefixoral be stored and disposed of?

How to Store and Dispose of Cefixime

The storage of cefixime products is strictly defined by regulatory labeling to maintain stability. Tablets, capsules, and the dry powder for oral suspension must be stored at Controlled Room Temperature, which ranges from 20 C to 25 C (68 F to 77 F). The medication must be protected from both light and moisture by keeping the container tightly closed and in its original packaging.

Stability and Child Safety

  • Reconstituted Suspension: Once prepared, the liquid suspension can be stored at room temperature or refrigerated, but it must be discarded after 14 days.
  • Prohibition: The product must not be frozen.
  • Safety: All forms of the medication must be stored out of the sight and reach of children.

Disposal

Disposal must comply with environmental and local regulations. Unused or expired cefixime should not be disposed of in household waste or wastewater (drains/toilets) and should instead be delivered to an approved pharmaceutical waste collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefixoral found in:

A-Z Index: